Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

SHE:002020 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	244.04	1,461	1,548	1,561	915.35	493.22
Short-Term Investments	-	-	-	-	70.21	90.26
Trading Asset Securities	865.55	150.96	366.89	422.4	1,179	1,948
Cash & Short-Term Investments	1,110	1,612	1,915	1,983	2,164	2,532
Cash Growth	-22.12%	-15.85%	-3.41%	-8.38%	-14.51%	20.50%
Accounts Receivable	875.95	612.58	509.57	510.67	379.93	479.12
Other Receivables	62.51	51.44	59.13	103.81	53.36	38.01
Receivables	938.46	664.02	568.7	614.47	433.29	517.14
Inventory	757.73	652.69	773.7	677.69	500.76	416.41
Prepaid Expenses	-	3.7	2.52	0.81	2.23	0.36
Other Current Assets	104.37	421.56	20.88	17.82	24.35	19.38
Total Current Assets	2,910	3,354	3,281	3,294	3,125	3,485
Property, Plant & Equipment	2,234	2,300	1,632	1,297	1,079	962.42
Long-Term Investments	610.04	1,124	1,134	882.21	681.06	446.43
Goodwill	348.48	348.48	348.48	348.48	257.89	257.89
Other Intangible Assets	387.06	401.26	418.59	157	150.77	166.57
Long-Term Deferred Tax Assets	82.22	80.98	75.11	68.64	43.97	48.57
Long-Term Deferred Charges	63.35	21.2	26.71	55.95	74.03	34.28
Other Long-Term Assets	1,948	356.72	446.73	443.95	254.71	223.76
Total Assets	8,583	7,987	7,363	6,547	5,666	5,625
Accounts Payable	1,100	941.16	719.12	449.79	369.05	456.56
Accrued Expenses	147.02	206.39	187.72	189.47	181.44	142.19
Short-Term Debt	352	279.09	238.58	148.33	300.13	358.5
Current Portion of Long-Term Debt	11.85	-	0.05	0.27	-	-
Current Portion of Leases	-	11.86	14.69	14.66	-	-
Current Income Taxes Payable	71.31	44.3	59.99	50.25	56.06	55.01
Current Unearned Revenue	35.78	53.35	81.01	47.61	48.14	-
Other Current Liabilities	645.23	538.61	514.23	521.88	592.04	758.03
Total Current Liabilities	2,363	2,075	1,815	1,422	1,547	1,770
Long-Term Debt	-	-	-	0.04	0.65	0.9
Long-Term Leases	24.06	31.23	42.98	30.62	-	-
Long-Term Unearned Revenue	259.57	268.81	270.6	128.73	138.7	122.3
Long-Term Deferred Tax Liabilities	75.46	68.4	59.68	65.44	46.55	20.14
Other Long-Term Liabilities	1.31	3.2	1.94	0.74	0.82	0.74
Total Liabilities	2,723	2,446	2,191	1,648	1,734	1,914
Common Stock	861.03	861.03	861.03	905.32	705.51	724.87
Additional Paid-In Capital	1,723	1,723	1,720	2,236	1,897	2,079
Retained Earnings	3,231	2,914	2,554	2,150	1,766	1,345
Treasury Stock	-	-	-	-437.62	-458.13	-458.13
Comprehensive Income & Other	14.07	13.86	11.31	8.05	6.37	4.99
Total Common Equity	5,829	5,512	5,146	4,862	3,918	3,696
Minority Interest	30.57	27.78	25.85	37.72	15.07	14.63
Shareholders' Equity	5,860	5,540	5,172	4,899	3,933	3,711
Total Liabilities & Equity	8,583	7,987	7,363	6,547	5,666	5,625
Total Debt	387.91	322.18	296.3	193.92	300.77	359.4
Net Cash (Debt)	721.68	1,290	1,619	1,789	1,864	2,172
Net Cash Growth	-28.97%	-20.35%	-9.51%	-4.00%	-14.22%	11.63%
Net Cash Per Share	0.84	1.50	1.88	2.19	2.34	2.54
Filing Date Shares Outstanding	861.03	861.03	861.03	861.03	807.73	941.14
Total Common Shares Outstanding	861.03	861.03	861.03	861.03	807.73	941.14
Working Capital	547.42	1,279	1,466	1,872	1,578	1,715
Book Value Per Share	6.77	6.40	5.98	5.65	4.85	3.93
Tangible Book Value	5,094	4,763	4,379	4,356	3,509	3,272
Tangible Book Value Per Share	5.92	5.53	5.09	5.06	4.34	3.48
Buildings	-	1,387	934.82	889.16	752.75	740.58
Machinery	-	1,412	1,219	946.45	803.63	696.32
Construction In Progress	-	482.06	284.91	161.34	139.84	54.3

Source: S&P Capital IQ. Standard template. Financial Sources.